Spero Therapeutics, Inc. (SPRO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.7762 |
| Open | 0.8114 |
| Bid | 0.8102 x 900 |
| Ask | 0.8849 x 900 |
| Day's range | 0.7762 - 0.8665 |
| 52-week range | 0.6800 - 19.8700 |
| Volume | |
| Avg. volume | 346,870 |
| Market cap | 29.807M |
| Beta (5Y monthly) | 1.94 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue Estimates
Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of 1.14% and 13.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Lags Revenue Estimates
Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of -16.09% and 27.40%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Clovis Oncology (CLVS) Reports Q1 Loss, Lags Revenue Estimates
Clovis (CLVS) delivered earnings and revenue surprises of -2.33% and 7.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2022 Yahoo. All rights reserved.
